Ovarian tissue cryopreservation (OTC) is transforming women's health—offering a natural way to preserve fertility, delay menopause, and support hormonal balance. Nichola Stones, a 45-year-old professional, highlights the impact of this innovation: "Revolutionary reproductive health services like OTC allow women to conceive later in life, giving us more choices." Dr. Summia Zaher emphasizes: "OTC meets a growing need in the region and offers a much-needed option for preserving reproductive health." Read more on Ovarian tissue cryopreservation and what this means for women's health on Gulf News https://bit.ly/4aOwVR6 Danat Al Emarat Hospital for Women & Children #WomensHealth #Fertility #DisruptingHealthcare #AI #PreventiveCare #TheFutureOfHealth #Health #Innovation
About us
M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care. M42 has over 20,000 employees and more than 450 facilities in 26 countries around the world. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and National Reference Laboratory, among others.
- Website
-
https://m42.ae/
External link for M42 Health
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Type
- Privately Held
Employees at M42 Health
Updates
-
We proudly signed an MoU with the General Secretariat of the Executive Council of Dubai, naming M42, Mubadala Health - Dubai, and SSBZHospital in Al Batayeh as Gold Sponsors of the Dubai Games. The signing ceremony took place at the iconic Emirates Towers, marking a significant step in our shared mission to promote sports and a healthy lifestyle across the UAE. Together, we aim to inspire healthier, stronger communities while championing the spirit of teamwork and resilience embodied by the Dubai Games. #DubaiGames2025 #M42 #MubadalaHealthDubai #SheikhSultanBinZayedHospital #PartnershipsForHealth #CommunityWellness
-
-
It’s with great enthusiasm and pride that I announce my new role as CEO of M42’s Digital Health Solutions platform part of our pivotal organizational restructuring, in addition to being the CEO of Abu Dhabi Health Data Services (ADHDS), the company representing the platform. With 20+ years in healthcare leadership, I’m excited to play a pivotal role in advancing M42’s mission of revolutionizing predictive, preventive, and personalized care. As we evolve into four distinct platforms: Global Patient Care, Integrated Health Solutions, Digital Health Solutions, and AI Life Sciences, we’re positioning ourselves to have a deeper, more far-reaching impact. Our restructuring allows us to move with greater agility and purpose, empowering each platform to drive innovation and scale. Through the integration of our expanding network of 480 facilities, 100+ service lines, and AI-driven technologies, we’re focused on building solutions that address today’s healthcare challenges and revolutionize care delivery on a global scale. In the past 18 months, ADHDS has undergone a tremendous transformation—from being an HIE operator to becoming a key regional system integrator with a growing global presence, delivering innovative solutions for the Department of Health and expanding our impact from Abu Dhabi to the world. I anticipate the possibilities and look forward to working alongside an incredible team to continue pushing the boundaries of what healthcare can be, while making a meaningful impact and lasting in the lives of patients everywhere. Kareem Shahin Malaffi (Abu Dhabi Health Information Exchange) #Longevity #DisruptingHealthcare #AI #PreventiveCare #TheFutureofHealth #PreventiveHealth #Innovation #Genomics #PrecisionMedicine #Health #Healthcare
-
-
As part of our mission to disrupt the traditional healthcare landscape, M42 is joining forces with Bahrain’s Royal Medical Services (RMS) to bring world-class heart and lung transplant treatments to Bahrain. With Cleveland Clinic Abu Dhabi’s expertise front and center, this game-changing partnership is opening doors to advanced care, ensuring better outcomes for patients across the region. Big things are happening in healthcare across the region, and this alliance is just the start. #Longevity #Innovation #FutureofHealthcare
-
-
M42 Health reposted this
M42 and the Bahrain Royal Medical Services have formed a strategic collaboration to improve access to heart and lung transplant care for Bahraini patients. #ClevelandClinicAbuDhabi, as the region’s leader in multi-organ transplants, will bring its specialized expertise to this partnership, ensuring patients receive the highest standard of care in Abu Dhabi from pre-operative assessments to post-operative follow-ups.
-
-
M42 Health reposted this
Early this morning at 4 AM, Harry embarked on an extraordinary quest to break the world record by covering 630 km in just 6 days! We are thrilled to support Harry on his remarkable journey. Join us in cheering him on as we also raise awareness about diabetes and the critical importance of physical health. Let’s go, Harry! Healthpoint M42 Health #7EmiratesRun #DiabetesAwareness
-
BioTwin, a cutting-edge digital health startup from Hub71, has teamed up with Cleveland Clinic Abu Dhabi, part of M42, to revolutionize breast cancer screening. Using its innovative virtual twin technology, BioTwin creates personalized digital replicas of patients to detect early signs of breast cancer with unmatched precision. This pilot project brings together BioTwin's breakthrough tech and Cleveland Clinic Abu Dhabi’s expertise to oncology. Powered by Microsoft Azure, this collaboration is pushing the boundaries of healthcare innovation in the UAE and beyond. #Longevity #Innovation #BioTwin #FutureofHealthcare #BreastCancerScreening #Hub71
-
-
As the 50th edition of Arab Health 2025 draws to a close, we reflect on a truly transformative week that embraced the power of innovation, collaboration, and a shared commitment to reimagine the future of healthcare through M42’s catalytic contributions to the industry. This year’s action and info-packed event has served as a pivotal occasion, bringing together leaders, innovators, and healthcare pioneers to discuss groundbreaking ideas and make tangible advancements that will have a lasting impact on people, patients, healthcare systems worldwide – and the planet. Over the past 4 days, we’ve embraced numerous bold partnerships and announcements that have truly set the stage for a healthier, more connected global healthcare landscape, serving as milestones that mark but the beginning of what’s to come. Stay with us as we continue to disrupt the status quo and pave the way for the tech-powered evolution of healthcare. #ArabHealth2025 #HealthcareInnovation #M42 #FutureOfHealth #PrecisionMedicine #PreventiveCare
-
It’s partnerships like this which are helping us advance precision, preventive and predictive care. We’re delighted to be teaming up with Hikma Pharmaceuticals on this important endeavor. #PrecisionHealth #Innovation #FutureofHealth #DisruptingHealthcare
#News for #media and #investors We are proud to announce the signing of a strategic Memorandum of Understanding (MoU) with M42 Health at Arab Health 2025. This collaboration strengthens our efforts in promoting Shield™, a US FDA-approved, non-invasive blood test for colorectal cancer screening. This MoU supports healthcare #innovation in the #UAE through more precise, preventive, and predictive cancer care programmes, using cutting-edge genomics technology for early cancer detection, to improve treatment outcomes. Read the full press release: https://lnkd.in/d7z95ysB #BetterHealth #WithinReach #EveryDay #Oncology #PrecisionMedicine Picture 1 (L-R): Signatories: Mr. Mazen Darwazah, Executive Vice Chairman & President of MENA - Hikma Pharmaceuticals and Dr. Fahed Al Marzooqi, CEO of Integrated Health Solutions Platform, M42. Witnesses: Dr. Sherif Shafick, Vice President of Hospital Business, MENA – Hikma Pharmaceuticals and Mr. Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42. Picture 2 (L-R): Dr. Sherif Shafick, Vice President of Hospital Business, MENA – Hikma Pharmaceuticals, Mr. Mazen Darwazah, Executive Vice Chairman & President of MENA – Hikma Pharmaceuticals, Mr. Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42 and Dr. Fahed Al Marzooqi, CEO of Integrated Health Solutions Platform, M42.
-